Clinical trials recruiting in Almelo, Netherlands

Phase breakdown

Conditions recruiting in Almelo, Netherlands

Recruiting trials in Almelo, Netherlands

• Anticoagulation for Stroke Prevention In Patients With Recent Episodes of Atrial Fibrillation Occurring Transiently With Stress
  NCT03968393 · Phase: Phase 4 · Ages: 55 Years and older · Sex: All (male and female)
• Circulating Tumor DNA Based Adjuvant Chemotherapy in Stage II Colon Cancer Patients: the MEDOCC-CrEATE Trial
  NCT06434896 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female)
• Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
  NCT07037433 · Phase: Phase 3 · Ages: 45 Years to 99 Years · Sex: All (male and female)
• Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
  NCT06677060 · Phase: Phase 3 · Ages: 40 Years and older · Sex: All (male and female)
• Prevention of Anthracycline-Induced Cardiac Dysfunction With Dexrazoxane in Patients With Diffuse Large-B Cell Lymphoma
  NCT06220032 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• Utrecht Cohort for Multiple Breast Cancer Intervention Studies and Long-term Evaluation - The UMBRELLA Cohort
  NCT02839863 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female)
• ctDNA-Based Adjuvant Chemotherapy for High-Risk Rectal Cancer
  NCT07188025 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)

Common questions

How many clinical trials are recruiting in Almelo, Netherlands?

7 recruiting trials have at least one study site in Almelo, Netherlands.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.